The International Academy of Compounding Pharmacists (IACP) announced today that it has enhanced its support of the compounding pharmacy profession with the establishment of the Partnership for Personalized Prescriptions.
The Partnership for Personalized Prescriptions or P3 is a new advocacy society that brings together over 150000 patients and practitioners who share a passion for compounding and are concerned about changes in prescription reimbursement programs that are increasingly threatening patient access to customized medicines.
P3 launched with a new website and social media channels on Facebook and Twitter which provide a forum for patients and practitioners to voice their support for compounding pharmacy or learn more about its important role in health care.
IACP is building on the association’s rich heritage of advocacy that began many years ago with the foundation of Patients and Professionals for Customized Care or P2C2.
“With the creation of the Partnership for Personalized Prescriptions we are expanding our original advocacy efforts and sharpening our tools to provide a strong platform to help raise compounding awareness as well as to restore the outstanding reputation of our profession” said Pat Stephens PharmD President of IACP and owner of Medi-Fare Drug an FDA-registered drug compounding outsourcing facility in Blacksburg S.C. “We encourage patients practitioners and pharmacists to join our effort to ensure continued access to personalized medicines.”
More: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=99692#.VCGBK0uskUU#ixzz3E9GdQPN6
No comments:
Post a Comment